Ora tackles thyroid eye disease with innovative clinical trials.

View organization page for Ora

49,320 followers

Emerging, challenging, and critical: Thyroid eye disease is one of the newest frontiers in Ora’s portfolio. The challenge: TED’s wide-ranging symptoms and variable progression make consistent endpoints and reliable measurements tough to achieve. Our approach: Ora combines deep ophthalmic trial expertise with rigorous imaging, clinical assessments, and standardised protocols to bring clarity to this complex indication. By partnering closely with investigators and sponsors, we help accelerate therapies that improve outcomes for patients living with TED. From our roots in ocular allergy to emerging indications like TED, Ora continues to lead with innovation and patient focus. #IndicationSpotlight #ThyroidEyeDisease #OphthalmologyResearch #ClinicalTrials #TeamOra

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories